|
(V1591) |
The role of the Connexin40A96S Mutation on electrophysiological properties of the structurally diseased mouse myocardium after transaortic constriction operation |
| |
|
J. W. Schrickel, T. Bualong, F. Stöckigt, R. Andrié, G. Nickenig, M. Linhart, R. Meyer (Bonn) |
|
|
Diskussion |
|
(V1592) |
New insights in the generation of atrial fibrillation: Effects of experimentally altered Na+/Ca2+ exchanger expression on arrhythmogenesis in murine atrial myocytes. |
| |
|
N. Bögeholz, P. Pauls, S. Kaese, J. S. Schulte, D. Dechering, G. Frommeyer, U. Kirchhefer, F. U. Müller, L. Eckardt, C. Pott (Münster) |
|
|
Diskussion |
|
(V1593) |
ATF4 induction in an in vitro cell culture model of atrial fibrillation |
| |
|
P. S. Lange, J. K. Freundt, G. Frommeyer, L. Eckardt (Münster) |
|
|
Diskussion |
|
(V1594) |
Increased inducibility of atrial fibrillation in a porcine model of arterial hypertension |
| |
|
M. Manninger, A. Alogna, D. Zweiker, J. Verderber, S. Reiter, B. Zirngast, B. Pieske, H. Post, D. Scherr (Graz, AT; Berlin) |
|
|
Diskussion |
|
(V1595) |
Phosphodiesterase 2 regulates resting heart rate and protects against arrhythmias and beta-adrenergic overstimulation |
| |
|
M. Dewenter, C. Vettel, M. Lindner, M. Riedel, S. Lämmle, F. Mason, S. Meinecke, T. Wieland, G. Vandecasteele, A. Geerts, F. Wunder, S. T. Sossalla, R. Fischmeister, A. El-Armouche (Göttingen, Mannheim, Dresden, Wuppertal; Châtenay-Malabry, FR) |
|
|
Diskussion |
|
(V1596) |
The combination of ranolazine and dronedarone as a novel treatment option for atrial fibrillation |
| |
|
N. Hartmann, I. Braun, F. Mason, N. Voigt, T. H. Fischer, L. S. Maier, G. Hasenfuß, S. T. Sossalla (Göttingen, Essen, Regensburg) |
|
|
Diskussion |